Study Type:
non randomized crossover study 2.4 1.6 -0.8 33% reduction * self rating scale: 1=not at all sleepy to 5=sleepy all the time Self Report of Compliance/Preference @3-10 months (patients were given choice of devices at the end of the study but the MAD was provided free of charge and they had to purchase the CPAP device) MAD use (MAD provided free of charge) all the time 81% intermittently 10% CPAP use (CPAP required purchase by patient) successful use 5%
Outcomes

Chose neither treatment 5%
Authors' Conclusions: The Herbst device achieved substantial success in most cases, but was less effective than CPAP especially for the more severe cases. In general, the device was strongly preferred over the CPAP by the subjects of this study.
Reviewer's Conclusions:
Results from this study suggest that the Herbst MAD is not as effective as nasal CPAP in reducing sleep apnea or hypoxemia. The effect of the Herbst on daytime sleepiness is unclear. If the study participants considered the Herbst MAD to be more comfortable than nasal CPAP, they would be more likely to report improvement in sleepiness with the former than with the latter. The degree to which patients prefer the Herbst MAD to nasal CPAP is difficult to discern from this study. Some of the observed patient preference for the Herbst is likely related to the fact that the Herbst device was provided free of charge while patients had to purchase the CPAP device. An important consideration in interpreting this study is whether the Herbst MAD will be as effective as nasal CPAP in preventing the long-term complications of obstructive sleep apnea. On the basis of the apnea/hypopnea index results, the Herbst MAD appears to be inferior in this regard.
